Your browser doesn't support javascript.
Chemical synthesis of super messenger RNA medicine.
Drug Delivery System ; 38(1):15-23, 2023.
Artículo en Japonés | EMBASE | ID: covidwho-20243538
ABSTRACT
Messenger RNAmRNAmedicine was urgently approved in 2020 as a vaccine for COVID-19 . However, current mRNA therapeutics are not fully established, with challenges remaining in translation efficiency and drug delivery system. Therefore, further research is needed to adapt mRNA therapeutics to other diseases. Furthermore, the preparation of mRNA drugs is time-consuming and costly because of the biological methods used. Our laboratory has been working on chemical methods to solve these issues. In this paper, we introduce chemical modifications and novel capping reactions as a method to improve the translation efficiency of mRNA and the introduction of disulfide modification to oligonucleotide therapeutics as an effort on the drug delivery system.Copyright © 2023, Japan Society of Drug Delivery System. All rights reserved.
Palabras clave

Texto completo: Disponible Colección: Bases de datos de organismos internacionales Base de datos: EMBASE Tópicos: Vacunas Idioma: Japonés Revista: Drug Delivery System Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos de organismos internacionales Base de datos: EMBASE Tópicos: Vacunas Idioma: Japonés Revista: Drug Delivery System Año: 2023 Tipo del documento: Artículo